| 1 | [SID17509142] | Active | Potency | 0.3294 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | Potency | 0.3294 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID17509142] | Active | IC50 | 1.672 | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | IC50 | 1.672 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651970 | | BioAssay type | confirmatory | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 3 | [SID17509142] | Active | IC50 | 1.672 | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | IC50 | 1.672 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651970 | | BioAssay type | confirmatory | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 4 | [SID17509142] | Active | IC50 | 2.029 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | IC50 | 2.029 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651968 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 5 | [SID17509142] | Active | IC50 | 2.029 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | IC50 | 2.029 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651968 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 6 | [SID17509142] | Active | IC50 | 2.029 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | IC50 | 2.029 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651968 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 7 | [SID17509142] | Active | IC50 | 8.7 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID651973, Type: confirmatory] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | IC50 | 8.7 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 651973 | | BioAssay type | confirmatory | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 8 | [SID17509142] | Active | Potency | 10 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 9 | [SID17509142] | Active | Potency | 10 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 10 | [SID17509142] | Active | | | High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment [AID2417, Type: screening] | polypyrimidine tract-binding protein 1 isoform a [Homo sapiens] [gi:4506243] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | BioAssay | High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment | | AID | 2417 | | BioAssay type | screening | | Target | polypyrimidine tract-binding protein 1 isoform a [Homo sapiens] [gi:4506243] | | PubMed | | | Data Table |  |
|
| 11 | [SID17509142] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 12 | [SID17509142] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 13 | [SID17509142] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 14 | [SID17509142] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 15 | [SID17509142] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 16 | [SID17509142] | Active | | | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity [AID651658, Type: screening] | FGF22 gene product [Homo sapiens] [gi:10190672] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Active | | BioAssay | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651658 | | BioAssay type | screening | | Target | FGF22 gene product [Homo sapiens] [gi:10190672] | | PubMed | | | Data Table |  |
|
| 17 | [SID17509142] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 18 | [SID17509142] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 19 | [SID17509142] | Inactive | Potency | 3.1623 | qHTS Assay for Inhibitors of the HIV-1 protein Vpr [AID651644, Type: confirmatory] | Vpr [Human immunodeficiency virus 1] [gi:28872817] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of the HIV-1 protein Vpr | | AID | 651644 | | BioAssay type | confirmatory | | Target | Vpr [Human immunodeficiency virus 1] [gi:28872817] | | PubMed | | | Data Table |  |
|
| 20 | [SID17509142] | Inactive | Potency | 10 | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction [AID2662, Type: confirmatory] | MLL gene product [Homo sapiens] [gi:56550039] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction | | AID | 2662 | | BioAssay type | confirmatory | | Target | MLL gene product [Homo sapiens] [gi:56550039] | | PubMed | | | Data Table |  |
|
| 21 | [SID17509142] | Inactive | IC50 | 35.882 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts [AID651969, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | IC50 | 35.882 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts | | AID | 651969 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID17509142] | Inactive | | | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library [AID651702, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library | | AID | 651702 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID17509142] | Inactive | | | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity [AID651661, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651661 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID17509142] | Inactive | | | VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID686996, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 686996 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID17509142] | Inactive | | | Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay [AID1020, Type: screening] | glucose-6-phosphate dehydrogenase [Leuconostoc mesenteroides] [gi:149631] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay | | AID | 1020 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase [Leuconostoc mesenteroides] [gi:149631] | | PubMed | | | Data Table |  |
|
| 26 | [SID17509142] | Inactive | Potency | | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 27 | [SID17509142] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. [AID2029, Type: screening] | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. | | AID | 2029 | | BioAssay type | screening | | Target | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] | | PubMed | | | Data Table |  |
|
| 28 | [SID17509142] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 29 | [SID17509142] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 30 | [SID17509142] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 31 | [SID17509142] | Inactive | | | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao. [AID1441, Type: screening] | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao. | | AID | 1441 | | BioAssay type | screening | | Target | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] | | PubMed | | | Data Table |  |
|
| 32 | [SID17509142] | Inactive | | | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao. [AID1441, Type: screening] | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao. | | AID | 1441 | | BioAssay type | screening | | Target | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] | | PubMed | | | Data Table |  |
|
| 33 | [SID17509142] | Inactive | | | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao. [AID1441, Type: screening] | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao. | | AID | 1441 | | BioAssay type | screening | | Target | guanine nucleotide-binding protein G(o) subunit alpha isoform a [Homo sapiens] [gi:10567816] | | PubMed | | | Data Table |  |
|
| 34 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 35 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 36 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 37 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 38 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 39 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 40 | [SID17509142] | Inactive | Potency | | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID2242, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 2242 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 41 | [SID17509142] | Inactive | Potency | | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID2242, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 2242 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 42 | [SID17509142] | Inactive | Potency | | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID2242, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 2242 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 43 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID1466, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 1466 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 44 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID1466, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 1466 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 45 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID1466, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 1466 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 46 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors of Human Galactokinase (GALK) [AID1868, Type: confirmatory] | galactokinase [Homo sapiens] [gi:4503895] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Galactokinase (GALK) | | AID | 1868 | | BioAssay type | confirmatory | | Target | galactokinase [Homo sapiens] [gi:4503895] | | PubMed | | | Data Table |  |
|
| 47 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors of Human Galactokinase (GALK) [AID1868, Type: confirmatory] | galactokinase [Homo sapiens] [gi:4503895] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Galactokinase (GALK) | | AID | 1868 | | BioAssay type | confirmatory | | Target | galactokinase [Homo sapiens] [gi:4503895] | | PubMed | | | Data Table |  |
|
| 48 | [SID17509142] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 49 | [SID17509142] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 50 | [SID17509142] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17509142 | | CID | 3140303 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|